Assembly Biosciences Inc reports results for the quarter ended in December - Earnings Summary

Assembly Biosciences

10/03/2022 23:05

* Assembly Biosciences Inc  ASMB.OQ  reported a quarterly
adjusted
loss of 38 cents​​ per share for the quarter ended in December.
The mean expectation of five analysts for the quarter was for a
loss of 48 cents per share.
    * Reported revenue was zero​;  analysts expected $1.25
million. 
    * Assembly Biosciences Inc's reported EPS for the quarter
was a
loss of $1.37​.
    * The mean earnings estimate of analysts had risen by
about 1.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Assembly Biosciences Inc shares had fallen by 32.6% this
quarter.
    * The company reported a quarterly loss of $60.26 million.
    * Wall Street's median 12-month price target for Assembly
Biosciences Inc is $14.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 10 at 11:05 p.m.  ​All
figures in US dollars unless otherwise stated